Anthropic's Long-Term Benefit Trust has appointed Vas Narasimhan, CEO of Novartis, to its Board of Directors. Narasimhan's extensive experience in developing and approving new medicines in a highly regulated industry is expected to aid Anthropic in safely scaling its AI technologies. His appointment signifies the Trust's commitment to balancing Anthropic's financial goals with its public benefit mission. AI
影响 Strengthens Anthropic's governance with expertise in responsible scaling of complex technologies.
排序理由 Appointment of a CEO from a major company (Novartis) to the board of a leading AI lab (Anthropic).
- Anthropic
- Chris Liddell
- Council on Foreign Relations
- Daniela Amodei
- Dario Amodei
- Harvard Medical School
- Jay Kreps
- Long-Term Benefit Trust
- Neil "Buddy" Shah
- Novartis
- Reed Hastings
- University of Chicago
- Vas Narasimhan
- Yasmin Razavi
AI 生成摘要 · Google Gemini · 来自 1 个来源。 我们如何撰写摘要 →
